Bio4t2
Chemicals & Related Products · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7310 Miramar Rd Ste 500, San Diego, Cali...Website
www.bio4t2.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bio4t2
Bio4t2 is a clinical-stage company focused on developing chimeric antigen receptor T cell (CAR-T) therapies specifically for treating solid tumors. Utilizing its proprietary platforms, including PrismCore, Bio-Engine, and Bio-Strike, Bio4t2 genetically modifies T cells to effectively target cancer cells while sparing normal tissues. The company's lead product, B4t2-001, is currently undergoing clinical testing and aims to address various cancers such as lung, colorectal, gastric, pancreatic, and breast cancers. Bio4t2's innovative approach enhances patient safety and treatment efficacy by incorporating a safety switch and enabling the targeting of multiple antigens simultaneously.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bio4t2 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Bio4t2 has new funding data
Check out if Bio4t2 is spiking on competitors!
Product Launch: Get notified when Bio4t2 launches new products
Bio4t2, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Bio4t2
Earning: See what the market has to say on Bio4t2 recently announced quarterly report
Click to see if Bio4t2 had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Bio4t2 has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Bio4t2
Find more new buyers
Compare Similar Companies to Bio4t2
Compare insights from companies similar to Bio4t2, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bio4t2
<$5M
11-50
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Bio4t2 is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bio4t2 is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bio4t2.
Bio4t2 News & Media
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bio4t2
Sign Up For FreeTo access detailed company insights
Bio4t2 is a clinical-stage company focused on developing chimeric antigen receptor T cell (CAR-T) therapies specifically for treating solid tumors. Utilizing its proprietary platforms, including PrismCore, Bio-Engine, and Bio-Strike, Bio4t2 genetically modifies T cells to effectively target cancer cells while sparing normal tissues. The company's l... Read More
